Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) 5/160/25 mg, Rx only, 7 Supply Disruption — Novartis Pharmaceuticals Corp
Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) 5/160/25 mg, Rx only, 7 Supply Disruption — Novartis Pharmaceuticals Corp is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) 5/160/25 mg, Rx only, 7; Manufacturer: Novar
| Drug name | Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) 5/160/25 mg, Rx only, 7 |
|---|---|
| Manufacturer | Novartis Pharmaceuticals Corp. |
| Recall/Disruption reason | Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, E |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-332-2014 |
| Initiation date | 20130808 |
| Quantity affected | 174,848 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →